Details for: ACTN4
Gene ID: 81
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: ACTN4
Ensembl ID: ENSG00000130402
Description: actinin alpha 4
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 67.03rCSI 70.21%PRS 8.41
-
CSI 64.66rCSI 80.42%PRS 9.62
-
CSI 58.61rCSI 89.52%PRS 9.07
-
CSI 56.12rCSI 54.02%PRS 9.36
-
CSI 50.97rCSI 49.14%PRS 5.92
-
CSI 50.31rCSI 44.66%PRS 9.05
-
CSI 44.33rCSI 71.49%PRS 14.48
-
CSI 44rCSI 43.91%PRS 7.76
-
CSI 42.71rCSI 45.38%PRS 16.15
-
CSI 42.23rCSI 39.9%PRS 9.44
-
CSI 41.59rCSI 48.85%PRS 10.77
-
CSI 41.23rCSI 36.26%PRS 6.56
-
CSI 37.71rCSI 82.59%PRS 12.19
-
CSI 37.48rCSI 46.36%PRS 7.93
-
CSI 36.92rCSI 71.8%PRS 9.22
-
CSI 35.52rCSI 41.2%PRS 13.46
-
CSI 35.05rCSI 40.53%PRS 6.62
-
CSI 34.95rCSI 50.1%PRS 12.41
-
CSI 33.73rCSI 51.59%PRS 14.71
-
CSI 32.83rCSI 42.1%PRS 10.43
-
CSI 31.45rCSI 54.4%PRS 6.91
-
CSI 29.44rCSI 24.68%PRS 10.82
-
CSI 29.11rCSI 69.2%PRS 13.59
-
CSI 28.79rCSI 30.09%PRS 9.55
-
CSI 28.56rCSI 60.79%PRS 14.61
-
CSI 27.9rCSI 72.11%PRS 8.44
-
CSI 26.32rCSI 66.58%PRS 11.29
-
CSI 26.08rCSI 38.21%PRS 46.47
-
CSI 25.95rCSI 62.27%PRS 16.76
-
CSI 24.81rCSI 54.62%PRS 13.87
-
CSI 24.6rCSI 33.63%PRS 10.28
-
CSI 24.31rCSI 65.54%PRS 11.68
-
CSI 24.31rCSI 37.35%PRS 12.98
-
CSI 23.97rCSI 38.28%PRS 9.86
-
CSI 23.76rCSI 56.65%PRS 29.13
-
CSI 23.67rCSI 67.71%PRS 16.69
-
CSI 23.45rCSI 100%PRS 9.03
-
CSI 23.37rCSI 36.12%PRS 8.47
-
CSI 23.06rCSI 30.65%PRS 9.86
-
CSI 22.56rCSI 42.64%PRS 19.88
-
CSI 22.35rCSI 64.71%PRS 10.25
-
CSI 22.02rCSI 31.42%PRS 10.23
-
CSI 21.47rCSI 44.54%PRS 9.03
-
CSI 21.13rCSI 55.63%PRS 17.74
-
CSI 20.54rCSI 29.11%PRS 8.5
-
CSI 20.2rCSI 44.1%PRS 18.4
-
CSI 20rCSI 71%PRS 14.84
-
CSI 19.72rCSI 37.01%PRS 17.91
-
CSI 19.64rCSI 15.23%PRS 8.63
-
CSI 19.24rCSI 47%PRS 9.15
-
CSI 18.85rCSI 52.83%PRS 14.07
-
CSI 18.78rCSI 63.48%PRS 15.5
-
CSI 18.7rCSI 26.83%PRS 7.19
-
CSI 18.41rCSI 26.93%PRS 9.57
-
CSI 18.08rCSI 43.94%PRS 5.18
-
CSI 17.95rCSI 49.48%PRS 8.94
-
CSI 17.06rCSI 24.98%PRS 10.59
-
CSI 16.83rCSI 82.94%PRS 12.29
-
CSI 16.8rCSI 17.53%PRS 9.29
-
CSI 16.64rCSI 73.07%PRS 16.93
-
CSI 15.96rCSI 11.14%PRS 9.54
-
CSI 15.09rCSI 27.66%PRS 44.13
-
CSI 14.98rCSI 15.52%PRS 10.64
-
CSI 14.76rCSI 77.51%PRS 16.77
-
CSI 14.68rCSI 20.33%PRS 13.02
-
CSI 14.43rCSI 23.37%PRS 9.24
-
CSI 14.37rCSI 38.4%PRS 8.27
-
CSI 14.28rCSI 41.31%PRS 20.29
-
CSI 14.15rCSI 33.58%PRS 11.79
-
CSI 13.87rCSI 11.5%PRS 8.58
-
CSI 13.85rCSI 19.96%PRS 14.6
-
CSI 12.93rCSI 24.66%PRS 14.54
-
CSI 12.83rCSI 33.34%PRS 12.57
-
CSI 12.83rCSI 32.55%PRS 7.01
-
CSI 12.57rCSI 22.41%PRS 15.45
-
CSI 12.49rCSI 29.12%PRS 22.17
-
CSI 12.07rCSI 16.15%PRS 9.87
-
CSI 11.86rCSI 16.14%PRS 13.88
-
CSI 11.61rCSI 8.71%PRS 26.55
-
CSI 11.41rCSI 40.03%PRS 16.41
-
CSI 11.3rCSI 8.43%PRS 15.28
-
CSI 11.17rCSI 19.58%PRS 6.66
-
CSI 11.15rCSI 61.88%PRS 31.18
-
CSI 10.55rCSI 24.58%PRS 20.29
-
CSI 10.44rCSI 11.74%PRS 14.64
-
CSI 10.25rCSI 48.04%PRS 24.61
-
CSI 10.21rCSI 74.68%PRS 25.25
-
CSI 10.14rCSI 32.89%PRS 11.09
-
CSI 10.05rCSI 29.84%PRS 14.2
-
CSI 10rCSI 27.47%PRS 15.08
-
CSI 9.64rCSI 7.65%PRS 15.94
-
CSI 9.56rCSI 12%PRS 11.54
-
CSI 9.34rCSI 9.18%PRS 9.82
-
CSI 9.14rCSI 15.65%PRS 12.14
-
CSI 9.13rCSI 6.09%PRS 24.64
-
CSI 9.09rCSI 26.18%PRS 17.97
-
CSI 8.93rCSI 20.37%PRS 8.16
-
CSI 8.57rCSI 64.39%PRS 16.79
-
CSI 8.53rCSI 65.39%PRS 38.82
-
CSI 8.45rCSI 6.65%PRS 10.78
-
CSI -10.7rCSI -15.9%PRS 10.4%
-
CSI -8.1rCSI -24.1%PRS 23.4%
-
CSI -7.2rCSI -11.5%PRS 5.9%
-
CSI -6.0rCSI -10.1%PRS 5.3%
-
CSI -5.8rCSI -18.1%PRS 6.2%
-
CSI -4.2rCSI -13.5%PRS 6.5%
-
CSI -3.9rCSI -5.0%PRS 8.8%
-
CSI -3.7rCSI -13.9%PRS 5.5%
-
CSI -2.5rCSI -4.3%PRS 18.4%
-
CSI -2.5rCSI -3.3%PRS 12.6%
-
CSI -1.1rCSI -4.6%PRS 21.8%
-
CSI -1.1rCSI -1.8%PRS 6.9%
-
CSI -1.0rCSI -4.7%PRS 5.7%
-
CSI -1.0rCSI -2.5%PRS 9.2%
-
CSI -0.5rCSI -3.7%PRS 4.3%
-
CSI -0.3rCSI -0.9%PRS 5.7%
-
CSI -0.1rCSI -0.2%PRS 25.6%
-
CSI 0.1rCSI 0.2%PRS 15.0%
-
CSI 0.1rCSI 0.7%PRS 2.1%
-
CSI 0.1rCSI 0.6%PRS 13.6%
-
CSI 0.1rCSI 0.3%PRS 7.3%
-
CSI 0.2rCSI 2.0%PRS 30.6%
-
CSI 0.2rCSI 0.3%PRS 11.2%
-
CSI 0.2rCSI 0.4%PRS 6.7%
-
CSI 0.2rCSI 3.6%PRS 24.1%
-
CSI 0.3rCSI 2.7%PRS 38.3%
-
CSI 0.3rCSI 1.7%PRS 7.2%
-
CSI 0.4rCSI 8.4%PRS 57.8%
-
CSI 0.4rCSI 7.5%PRS 8.1%
-
CSI 0.4rCSI 2.1%PRS 22.9%
-
CSI 0.4rCSI 1.0%PRS 15.2%
-
CSI 0.4rCSI 0.6%PRS 7.0%
-
CSI 0.4rCSI 1.5%PRS 19.1%
-
CSI 0.4rCSI 0.6%PRS 14.3%
-
CSI 0.4rCSI 2.6%PRS 20.6%
-
CSI 0.5rCSI 0.7%PRS 8.5%
-
CSI 0.5rCSI 6.5%PRS 52.8%
-
CSI 0.5rCSI 5.7%PRS 16.5%
-
CSI 0.5rCSI 2.6%PRS 11.9%
-
CSI 0.5rCSI 3.8%PRS 11.3%
-
CSI 0.6rCSI 3.2%PRS 14.2%
-
CSI 0.6rCSI 1.4%PRS 10.2%
-
CSI 0.7rCSI 3.8%PRS 41.7%
-
CSI 0.7rCSI 1.2%PRS 5.3%
-
CSI 0.7rCSI 2.9%PRS 12.7%
-
CSI 0.7rCSI 14.4%PRS 7.3%
-
CSI 0.7rCSI 0.6%PRS 8.0%
-
CSI 0.8rCSI 1.1%PRS 8.6%
-
CSI 0.8rCSI 2.3%PRS 16.0%
-
CSI 0.8rCSI 1.2%PRS 8.1%
-
CSI 0.9rCSI 4.1%PRS 12.6%
-
CSI 0.9rCSI 4.8%PRS 31.1%
-
CSI 0.9rCSI 5.9%PRS 55.6%
-
CSI 0.9rCSI 1.0%PRS 18.7%
-
CSI 0.9rCSI 6.0%PRS 30.1%
-
CSI 0.9rCSI 1.9%PRS 19.1%
-
CSI 0.9rCSI 4.8%PRS 18.1%
-
CSI 0.9rCSI 4.4%PRS 19.3%
-
CSI 1.0rCSI 5.5%PRS 28.8%
-
CSI 1.0rCSI 2.3%PRS 5.6%
-
CSI 1.0rCSI 5.9%PRS 38.4%
-
CSI 1.1rCSI 5.9%PRS 3.3%
-
CSI 1.1rCSI 3.1%PRS 32.3%
-
CSI 1.1rCSI 18.7%PRS 36.9%
-
CSI 1.1rCSI 3.7%PRS 37.4%
-
CSI 1.1rCSI 2.7%PRS 4.8%
-
CSI 1.1rCSI 6.6%PRS 13.6%
-
CSI 1.1rCSI 1.6%PRS 19.1%
-
CSI 1.2rCSI 6.3%PRS 17.2%
-
CSI 1.2rCSI 11.8%PRS 27.7%
-
CSI 1.2rCSI 1.1%PRS 10.2%
-
CSI 1.2rCSI 14.1%PRS 36.1%
-
CSI 1.3rCSI 8.0%PRS 32.0%
-
CSI 1.3rCSI 5.7%PRS 28.0%
-
CSI 1.4rCSI 4.4%PRS 12.2%
-
CSI 1.4rCSI 3.0%PRS 6.5%
-
CSI 1.4rCSI 14.7%PRS 13.5%
-
CSI 1.5rCSI 2.4%PRS 15.8%
-
CSI 1.5rCSI 2.1%PRS 17.3%
-
CSI 1.6rCSI 2.2%PRS 9.4%
-
CSI 1.6rCSI 6.7%PRS 24.2%
-
CSI 1.6rCSI 3.3%PRS 14.2%
-
CSI 1.6rCSI 24.2%PRS 29.5%
-
CSI 1.6rCSI 5.3%PRS 4.3%
-
CSI 1.6rCSI 3.8%PRS 14.6%
-
CSI 1.6rCSI 2.1%PRS 5.7%
-
CSI 1.7rCSI 16.4%PRS 34.2%
-
CSI 1.7rCSI 1.5%PRS 10.3%
-
CSI 1.7rCSI 4.4%PRS 15.1%
-
CSI 1.7rCSI 3.4%PRS 24.9%
-
CSI 1.7rCSI 4.1%PRS 14.4%
-
CSI 1.7rCSI 3.5%PRS 9.7%
-
CSI 1.8rCSI 2.8%PRS 11.7%
-
CSI 1.8rCSI 2.1%PRS 15.8%
-
CSI 1.8rCSI 2.2%PRS 9.0%
-
CSI 1.8rCSI 2.2%PRS 12.7%
-
CSI 1.8rCSI 2.3%PRS 13.9%
-
CSI 1.9rCSI 3.0%PRS 7.8%
-
CSI 1.9rCSI 11.9%PRS 29.8%
-
CSI 1.9rCSI 12.7%PRS 23.8%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 135020461
Symbol: ACTN4_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 10656685
Title: The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells.
PubMed ID: 10656685
PubMed ID: 22567897
Title: Novel splicing isoform of actin-binding protein alpha-actinin 4 in epidermoid carcinoma cells A431.
PubMed ID: 22567897
PubMed ID: 15057824
Title: The DNA sequence and biology of human chromosome 19.
PubMed ID: 15057824
DOI: 10.1038/nature02399
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 17974005
Title: The full-ORF clone resource of the German cDNA consortium.
PubMed ID: 17974005
PubMed ID: 16344560
Title: Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.
PubMed ID: 16344560
DOI: 10.1101/gr.4039406
PubMed ID: 9508771
Title: Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion.
PubMed ID: 9508771
PubMed ID: 12042308
Title: Interaction of two actin-binding proteins, synaptopodin and alpha-actinin-4, with the tight junction protein MAGI-1.
PubMed ID: 12042308
PubMed ID: 15772161
Title: CART: an Hrs/actinin-4/BERP/myosin V protein complex required for efficient receptor recycling.
PubMed ID: 15772161
PubMed ID: 17289661
Title: Molecular composition of IMP1 ribonucleoprotein granules.
PubMed ID: 17289661
PubMed ID: 19608861
Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.
PubMed ID: 19608861
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 22689882
Title: EWI-2 association with alpha-actinin regulates T cell immune synapses and HIV viral infection.
PubMed ID: 22689882
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 25944712
Title: N-terminome analysis of the human mitochondrial proteome.
PubMed ID: 25944712
PubMed ID: 33228246
Title: ACTN4 Mediates SEPT14 Mutation-Induced Sperm Head Defects.
PubMed ID: 33228246
PubMed ID: 15988023
Title: Structural dynamics of alpha-actinin-vinculin interactions.
PubMed ID: 15988023
PubMed ID: 18164029
Title: Crystal structure of the actin-binding domain of alpha-actinin-4 Lys255Glu mutant implicated in focal segmental glomerulosclerosis.
PubMed ID: 18164029
PubMed ID: 22351778
Title: Familial focal segmental glomerulosclerosis (FSGS)-linked alpha-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors.
PubMed ID: 22351778
PubMed ID: 10700177
Title: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.
PubMed ID: 10700177
DOI: 10.1038/73456
PubMed ID: 18436095
Title: Familial focal segmental glomerulosclerosis associated with an ACTN4 mutation and paternal germline mosaicism.
PubMed ID: 18436095
PubMed ID: 22732337
Title: Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients.
PubMed ID: 22732337
DOI: 10.5414/cn107320
PubMed ID: 23890478
Title: Mutational analysis of ACTN4, encoding alpha-actinin 4, in patients with focal segmental glomerulosclerosis using HRM method.
PubMed ID: 23890478
PubMed ID: 23014460
Title: Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis.
PubMed ID: 23014460
DOI: 10.1038/ki.2012.349
Sequence Information:
- Length: 911
- Mass: 104854
- Checksum: 461580C3F22937D1
- Sequence:
MVDYHAANQS YQYGPSSAGN GAGGGGSMGD YMAQEDDWDR DLLLDPAWEK QQRKTFTAWC NSHLRKAGTQ IENIDEDFRD GLKLMLLLEV ISGERLPKPE RGKMRVHKIN NVNKALDFIA SKGVKLVSIG AEEIVDGNAK MTLGMIWTII LRFAIQDISV EETSAKEGLL LWCQRKTAPY KNVNVQNFHI SWKDGLAFNA LIHRHRPELI EYDKLRKDDP VTNLNNAFEV AEKYLDIPKM LDAEDIVNTA RPDEKAIMTY VSSFYHAFSG AQKAETAANR ICKVLAVNQE NEHLMEDYEK LASDLLEWIR RTIPWLEDRV PQKTIQEMQQ KLEDFRDYRR VHKPPKVQEK CQLEINFNTL QTKLRLSNRP AFMPSEGKMV SDINNGWQHL EQAEKGYEEW LLNEIRRLER LDHLAEKFRQ KASIHEAWTD GKEAMLKHRD YETATLSDIK ALIRKHEAFE SDLAAHQDRV EQIAAIAQEL NELDYYDSHN VNTRCQKICD QWDALGSLTH SRREALEKTE KQLEAIDQLH LEYAKRAAPF NNWMESAMED LQDMFIVHTI EEIEGLISAH DQFKSTLPDA DREREAILAI HKEAQRIAES NHIKLSGSNP YTTVTPQIIN SKWEKVQQLV PKRDHALLEE QSKQQSNEHL RRQFASQANV VGPWIQTKME EIGRISIEMN GTLEDQLSHL KQYERSIVDY KPNLDLLEQQ HQLIQEALIF DNKHTNYTME HIRVGWEQLL TTIARTINEV ENQILTRDAK GISQEQMQEF RASFNHFDKD HGGALGPEEF KACLISLGYD VENDRQGEAE FNRIMSLVDP NHSGLVTFQA FIDFMSRETT DTDTADQVIA SFKVLAGDKN FITAEELRRE LPPDQAEYCI ARMAPYQGPD AVPGALDYKS FSTALYGESD L
Genular Protein ID: 2303997419
Symbol: H7C144_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11237011
Title: Initial sequencing and analysis of the human genome.
PubMed ID: 11237011
DOI: 10.1038/35057062
PubMed ID: 15057824
Title: The DNA sequence and biology of human chromosome 19.
PubMed ID: 15057824
DOI: 10.1038/nature02399
PubMed ID: 15496913
Title: Finishing the euchromatic sequence of the human genome.
PubMed ID: 15496913
DOI: 10.1038/nature03001
PubMed ID: 19608861
Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.
PubMed ID: 19608861
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 25944712
Title: N-terminome analysis of the human mitochondrial proteome.
PubMed ID: 25944712
Sequence Information:
- Length: 906
- Mass: 104327
- Checksum: 85B7706D09DAFED7
- Sequence:
MVDYHAANQS YQYGPSSAGN GAGGGGSMGD YMAQEDDWDR DLLLDPAWEK QQRKTFTAWC NSHLRKAGTQ IENIDEDFRD GLKLMLLLEV ISGERLPKPE RGKMRVHKIN NVNKALDFIA SKGVKLVSIG AEEIVDGNAK MTLGMIWTII LRFAIQDISV EETSAKEGLL LWCQRKTAPY KNVNVQNFHI SWKDGLAFNA LIHRHRPELI EYDKLRKDDP VTNLNNAFEV AEKYLDIPKM LDAEDIVGTL RPDEKAIMTY VSCFYHAFSG AQKAETAANR ICKVLAVNQE NEHLMEDYEK LASDLLEWIR RTIPWLEDRV PQKTIQEMQQ KLEDFRDYRR VHKPPKVQEK CQLEINFNTL QTKLRLSNRP AFMPSEGKMV SDINNGWQHL EQAEKGYEEW LLNEIRRLER LDHLAEKFRQ KASIHEAWTD GKEAMLKHRD YETATLSDIK ALIRKHEAFE SDLAAHQDRV EQIAAIAQEL NELDYYDSHN VNTRCQKICD QWDALGSLTH SRREALEKTE KQLEAIDQLH LEYAKRAAPF NNWMESAMED LQDMFIVHTI EEIEGLISAH DQFKSTLPDA DREREAILAI HKEAQRIAES NHIKLSGSNP YTTVTPQIIN SKWEKVQQLV PKRDHALLEE QSKQQSNEHL RRQFASQANV VGPWIQTKME EIGRISIEMN GTLEDQLSHL KQYERSIVDY KPNLDLLEQQ HQLIQEALIF DNKHTNYTME HIRVGWEQLL TTIARTINEV ENQILTRDAK GISQEQMQEF RASFNHFDKK QTGSMDSDDF RALLISTGYS LGEAEFNRIM SLVDPNHSGL VTFQAFIDFM SRETTDTDTA DQVIASFKVL AGDKNFITAE ELRRELPPDQ AEYCIARMAP YQGPDAVPGA LDYKSFSTAL YGESDL